Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Compared with camptothecin, Topotecan hydrochloride has lower toxicity and higher anti-tumor activity. It was approved for market in 1996 and is clinically used for the treatment of advanced colon cancer, rectal cancer, ovarian cancer and small cell lung cancer